Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,080 | -2,473 | -8,892 | -6,145 | -3,753 |
| Depreciation Amortization | 2 | 1 | 4 | 3 | 2 |
| Accounts payable and accrued liabilities | 1,079 | 90 | 36 | 10 | 80 |
| Other Working Capital | 1,059 | 95 | 32 | 34 | 39 |
| Other Operating Activity | 110 | 504 | 2,343 | 1,774 | 1,110 |
| Operating Cash Flow | $-2,830 | $-1,783 | $-6,479 | $-4,324 | $-2,524 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,066 | 299 | N/A | N/A | N/A |
| Financing Cash Flow | $3,066 | $299 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 6,989 | 6,989 | 13,468 | 13,468 | 13,468 |
| End Cash Position | 7,225 | 5,506 | 6,989 | 9,144 | 10,944 |
| Net Cash Flow | $236 | $-1,483 | $-6,479 | $-4,324 | $-2,524 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,830 | -1,783 | -6,479 | -4,324 | -2,524 |
| Free Cash Flow | -2,830 | -1,783 | -6,479 | -4,324 | -2,524 |